Management of Duodenitis
For duodenitis management, proton pump inhibitors (PPIs) such as omeprazole are the first-line treatment, especially for gastroduodenal disease where symptoms are often relieved by these medications. 1
Diagnostic Approach
- Endoscopic evaluation is essential to confirm diagnosis and assess severity
- Biopsies should be taken to rule out H. pylori infection, which has a high prevalence (100%) in erosive duodenitis 2
- Test for NSAID use, which is a common cause of duodenitis 3, 4
Treatment Algorithm
First-line Treatment:
Proton Pump Inhibitors
H. pylori Eradication (if positive)
For NSAID-induced Duodenitis:
- Discontinue NSAIDs if possible 4
- If NSAIDs must be continued:
For Refractory Cases:
- Consider histamine H2-receptor antagonists as an alternative to PPIs 3
- Mucosal protective agents like rebamipide or teprenone may be beneficial 3
- For severe cases with inflammation, metronidazole 10-20 mg/kg/day may be considered, though not as first-line therapy 1
Special Considerations
Inflammatory Bowel Disease-Associated Duodenitis:
If duodenitis is part of Crohn's disease presentation:
- Corticosteroids may be needed for active disease 1
- Nutritional support as adjunctive therapy 1
- Consider immunomodulators (azathioprine 1.5-2.5 mg/kg/day) for maintenance 1
Immune Checkpoint Inhibitor-Related Duodenitis:
- Hold immunotherapy until recovery to Grade 1
- Corticosteroids starting with 1 mg/kg/day prednisone until symptoms improve to Grade 1
- Taper over 4-6 weeks 1
Follow-up
- Repeat endoscopy after 4-8 weeks of therapy to confirm healing
- For H. pylori-associated duodenitis, confirm eradication with urea breath test 4 weeks after completing therapy 2
- Long-term PPI therapy may be needed for recurrent cases
Common Pitfalls
- Failure to test for H. pylori infection, which has high prevalence in duodenitis
- Overlooking NSAID use as a potential cause
- Inadequate duration of PPI therapy
- Not confirming H. pylori eradication after treatment
- Continuing NSAIDs without gastroprotection
The evidence strongly supports that duodenitis should be treated similarly to duodenal ulcer disease, with PPIs as the cornerstone of therapy and H. pylori eradication when present 2.